Geron Net Worth

Geron Net Worth Breakdown

  GERN
The net worth of Geron is the difference between its total assets and liabilities. Geron's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Geron's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Geron's net worth can be used as a measure of its financial health and stability which can help investors to decide if Geron is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Geron stock.

Geron Net Worth Analysis

Geron's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Geron's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Geron's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Geron's net worth analysis. One common approach is to calculate Geron's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Geron's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Geron's net worth. This approach calculates the present value of Geron's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Geron's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Geron's net worth. This involves comparing Geron's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Geron's net worth relative to its peers.

Enterprise Value

1.15 Billion

2702474514199201.2B1.1B1.2B-8%82%-7%119%33%-10%5%100%
To determine if Geron is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Geron's net worth research are outlined below:
Geron generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 237 K. Net Loss for the year was (184.13 M) with loss before overhead, payroll, taxes, and interest of (82.9 M).
Geron currently holds about 219.29 M in cash with (167.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Geron has a frail financial position based on the latest SEC disclosures
Over 82.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Scott Samuels of 1350000 shares of Geron at 3.21 subject to Rule 16b-3
Geron uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Geron. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Geron's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Geron Target Price Consensus

Geron target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Geron's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   9  Strong Buy
Strong BuyBuyStrong Buy55.6%Buy44.4%Hold0.0%Sell0.0%Strong Sell0.0%100%
Most Geron analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Geron stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Geron, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Geron Target Price Projection

Geron's current and average target prices are 2.37 and 7.61, respectively. The current price of Geron is the price at which Geron is currently trading. On the other hand, Geron's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Geron Market Quote on 25th of February 2025

Low Price2.32Odds
High Price2.42Odds

2.37

Target Price

Analyst Consensus On Geron Target Price

Low Estimate6.93Odds
High Estimate8.45Odds

7.6111

Historical Lowest Forecast  6.93 Target Price  7.61 Highest Forecast  8.45
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Geron and the information provided on this page.

Know Geron's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Geron is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Geron backward and forwards among themselves. Geron's institutional investor refers to the entity that pools money to purchase Geron's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-12-31
13.1 M
Morgan Stanley - Brokerage Accounts2024-12-31
11.7 M
Woodline Partners Lp2024-12-31
11.6 M
Vestal Point Capital Lp2024-12-31
11 M
Darwin Global Management, Ltd.2024-12-31
9.6 M
Segall Bryant & Hamill2024-12-31
7.4 M
Eventide Asset Management, Llc2024-12-31
7.1 M
Millennium Management Llc2024-12-31
M
Braidwell Lp2024-12-31
M
Blackrock Inc2024-12-31
49.9 M
Vanguard Group Inc2024-12-31
33.5 M
Note, although Geron's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Geron's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.44 B.

Market Cap

1.14 Billion

100%

Project Geron's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.42)(0.44)
Return On Capital Employed(0.78)(0.82)
Return On Assets(0.42)(0.44)
Return On Equity(0.67)(0.70)
When accessing Geron's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Geron's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Geron's profitability and make more informed investment decisions.

Evaluate Geron's management efficiency

Geron has return on total asset (ROA) of (0.303) % which means that it has lost $0.303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6903) %, meaning that it created substantial loss on money invested by shareholders. Geron's management efficiency ratios could be used to measure how well Geron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of February 2025, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.82. At this time, Geron's Total Assets are very stable compared to the past year. As of the 25th of February 2025, Non Current Assets Total is likely to grow to about 63.7 M, while Other Current Assets are likely to drop about 4 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.50  0.47 
Tangible Book Value Per Share 0.50  0.47 
Enterprise Value Over EBITDA(6.28)(5.97)
Price Book Value Ratio 4.37  2.86 
Enterprise Value Multiple(6.28)(5.97)
Price Fair Value 4.37  2.86 
Enterprise Value1.1 B1.2 B
The strategic initiatives led by Geron's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue
40.34
Revenue
29.5 M
Quarterly Revenue Growth
171.384
Revenue Per Share
0.047
Return On Equity
(0.69)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geron insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geron's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Geron insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Geron Corporate Filings

F4
20th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
14th of February 2025
Other Reports
ViewVerify
8K
13th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10th of January 2025
Other Reports
ViewVerify
Geron time-series forecasting models is one of many Geron's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Geron's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Geron Earnings Estimation Breakdown

The calculation of Geron's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Geron is estimated to be -0.069925 with the future projection ranging from a low of -0.0745 to a high of -0.065. Please be aware that this consensus of annual earnings estimates for Geron is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.04
-0.07
Lowest
Expected EPS
-0.069925
-0.07
Highest

Geron Earnings Projection Consensus

Suppose the current estimates of Geron's value are higher than the current market price of the Geron stock. In this case, investors may conclude that Geron is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Geron's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
974.02%
-0.04
-0.069925
-0.32

Geron Earnings per Share Projection vs Actual

Actual Earning per Share of Geron refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Geron predict the company's earnings will be in the future. The higher the earnings per share of Geron, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.
JavaScript chart by amCharts 3.21.15SepMarMarSepDec-0.15-0.10-0.050.00
JavaScript chart by amCharts 3.21.15Highest Estimate Lowest Estimate Estimated EPS Actual EPS

Geron Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Geron, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Geron should always be considered in relation to other companies to make a more educated investment decision.
JavaScript chart by amCharts 3.21.15SepMarMarSepDec-0.14-0.12-0.10-0.08-0.06-0.04-0.020.00
JavaScript chart by amCharts 3.21.15Actual Estimated

Geron Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Geron's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.08-0.040.0450 
2024-08-08
2024-06-30-0.1-0.10.0
2024-05-02
2024-03-31-0.1-0.090.0110 
2024-02-28
2023-12-31-0.1-0.090.0110 
2023-11-02
2023-09-30-0.1-0.080.0220 
2023-08-03
2023-06-30-0.08-0.09-0.0112 
2023-05-11
2023-03-31-0.1-0.070.0330 
2023-03-16
2022-12-31-0.12-0.10.0216 
2022-11-03
2022-09-30-0.09-0.1-0.0111 
2022-08-11
2022-06-30-0.09-0.070.0222 
2022-05-09
2022-03-31-0.1-0.090.0110 
2022-03-10
2021-12-31-0.08-0.1-0.0225 
2021-11-09
2021-09-30-0.09-0.080.0111 
2021-08-16
2021-06-30-0.09-0.090.0
2021-05-10
2021-03-31-0.08-0.09-0.0112 
2021-03-11
2020-12-31-0.06-0.07-0.0116 
2020-11-05
2020-09-30-0.06-0.060.0
2020-08-06
2020-06-30-0.06-0.060.0
2020-05-28
2020-03-31-0.12-0.080.0433 
2020-03-12
2019-12-31-0.2-0.150.0525 
2019-11-06
2019-09-30-0.15-0.080.0746 
2019-08-01
2019-06-30-0.09-0.080.0111 
2019-05-02
2019-03-31-0.07-0.050.0228 
2019-03-07
2018-12-31-0.04-0.040.0
2018-11-01
2018-09-30-0.05-0.030.0240 
2018-07-31
2018-06-30-0.04-0.040.0
2018-05-10
2018-03-31-0.04-0.040.0
2018-03-16
2017-12-31-0.05-0.050.0
2017-11-01
2017-09-30-0.05-0.040.0120 
2017-08-09
2017-06-30-0.05-0.040.0120 
2017-05-09
2017-03-31-0.05-0.050.0
2017-03-01
2016-12-31-0.06-0.050.0116 
2016-11-03
2016-09-30-0.06-0.020.0466 
2016-08-03
2016-06-30-0.07-0.050.0228 
2016-05-05
2016-03-31-0.05-0.06-0.0120 
2016-02-25
2015-12-31-0.05-0.050.0
2015-11-05
2015-09-300.110.170.0654 
2015-08-05
2015-06-30-0.06-0.050.0116 
2015-04-30
2015-03-31-0.06-0.060.0
2015-03-03
2014-12-310.050.080.0360 
2014-11-03
2014-09-30-0.06-0.060.0
2014-08-11
2014-06-30-0.06-0.060.0
2014-05-01
2014-03-31-0.06-0.060.0
2014-03-17
2013-12-31-0.07-0.070.0
2013-11-07
2013-09-30-0.06-0.060.0
2013-08-08
2013-06-30-0.07-0.060.0114 
2013-04-25
2013-03-31-0.08-0.09-0.0112 
2013-03-12
2012-12-31-0.14-0.10.0428 
2012-10-30
2012-09-30-0.14-0.130.01
2012-07-31
2012-06-30-0.14-0.140.0
2012-05-02
2012-03-31-0.18-0.150.0316 
2012-03-07
2011-12-31-0.2-0.190.01
2011-11-03
2011-09-30-0.18-0.160.0211 
2011-07-28
2011-06-30-0.17-0.170.0
2011-04-27
2011-03-31-0.19-0.2-0.01
2011-02-24
2010-12-31-0.19-0.24-0.0526 
2010-10-28
2010-09-30-0.2-0.190.01
2010-07-29
2010-06-30-0.19-0.180.01
2010-04-28
2010-03-31-0.19-0.180.01
2010-02-25
2009-12-31-0.17-0.2-0.0317 
2009-10-29
2009-09-30-0.21-0.170.0419 
2009-07-30
2009-06-30-0.19-0.23-0.0421 
2009-04-29
2009-03-31-0.2-0.20.0
2009-02-26
2008-12-31-0.21-0.22-0.01
2008-10-30
2008-09-30-0.17-0.22-0.0529 
2008-07-30
2008-06-30-0.2-0.170.0315 
2008-04-29
2008-03-31-0.18-0.180.0
2008-02-27
2007-12-31-0.18-0.22-0.0422 
2007-10-30
2007-09-30-0.2-0.170.0315 
2007-07-30
2007-06-30-0.18-0.19-0.01
2007-04-27
2007-03-31-0.17-0.030.1482 
2007-03-16
2006-12-31-0.16-0.2-0.0425 
2006-10-30
2006-09-30-0.16-0.150.01
2006-07-31
2006-06-30-0.15-0.140.01
2006-04-28
2006-03-31-0.16-0.140.0212 
2006-02-28
2005-12-31-0.17-0.140.0317 
2005-11-04
2005-09-30-0.13-0.21-0.0861 
2005-08-05
2005-06-30-0.18-0.060.1266 
2005-02-25
2004-12-31-0.21-0.20.01
2004-10-29
2004-09-30-0.21-0.23-0.02
2003-11-12
2003-09-30-0.3-0.150.1550 
2003-07-30
2003-06-30-0.31-0.32-0.01
2002-05-06
2002-03-31-0.25-0.43-0.1872 
2002-02-26
2001-12-31-0.46-0.85-0.3984 
1998-11-13
1998-09-30-0.35-0.250.128 
1998-08-07
1998-06-30-0.33-0.220.1133 
1998-03-02
1997-12-31-0.23-0.140.0939 
1997-11-12
1997-09-30-0.23-0.180.0521 
1997-08-11
1997-06-30-0.15-0.17-0.0213 
1997-05-09
1997-03-31-0.2-0.44-0.24120 
1997-03-07
1996-12-31-0.25-0.31-0.0624 

Geron Corporate Management

Andrew GrethleinExecutive VP of Devel. and Technical OperationsProfile
Faye MDExecutive OfficerProfile
Stephen JDChief VPProfile
Aron FeingoldVice CommunicationsProfile
James MBAExecutive OfficerProfile
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…100%